Aarti Pharmalabs Limited
NSE: AARTIPHARM · Healthcare
₹834.95
-8.20 (-0.97%)
Last close · 30 Aug 2026, 2:51 am IST
- Open
- ₹844.00
- Day high
- ₹851.20
- Day low
- ₹826.60
- Volume
- 3.87 L
- Prev close
- ₹843.15
Price chart
Range
EMA
Also show
Fundamentals
Drug Manufacturers - Specialty & Generic
Valuation
- Market Cap
- 6,110 Cr
- Price
- 673.80
- P/E (TTM)
- 34.97
- P/E (Fwd)
- 26.42
- P/B
- 2.88
- EV/EBITDA
- 17.13
- EV/Revenue
- 3.79
- PEG
- —
- Div Yield
- 0.59%
- 52W High
- 954.00
- 52W Low
- 585.00
- Beta
- 0.22
Profitability & income
- Revenue (TTM)
- 1,819 Cr
- Net Income (TTM)
- 175 Cr
- EBITDA
- 402 Cr
- Gross Margin
- 54.12%
- Op. Margin
- 17.50%
- Net Margin
- 9.60%
- ROE
- 8.49%
- ROA
- 5.83%
- EPS (TTM)
- 19.27
- EPS (Fwd)
- 25.50
Financial health
- Total Debt
- 794 Cr
- Total Cash
- 10 Cr
- Debt/Equity
- 37.36
- Current Ratio
- 1.49
- Quick Ratio
- 0.64
- Book Value
- 234.28
- Free Cash Flow
- -166 Cr
- Op. Cash Flow
- 262 Cr
Growth
- Revenue Growth
- 3.30%
- Earnings Growth
- -30.80%
- Earnings QoQ
- -30.80%
Quarterly results
| Period | Revenue | Net Income | EBITDA | Op. Income | Gross Profit | Op. Cash Flow | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 583 Cr | 61 Cr | 127 Cr | 102 Cr | 300 Cr | — | 754 Cr | 2,125 Cr |
| 2025-12-31 | 432 Cr | 48 Cr | 104 Cr | 74 Cr | 260 Cr | — | — | — |
| 2025-09-30 | 418 Cr | 28 Cr | 74 Cr | 50 Cr | 209 Cr | — | 659 Cr | 2,046 Cr |
| 2025-06-30 | 386 Cr | 50 Cr | 95 Cr | 72 Cr | 217 Cr | — | — | — |
| 2025-03-31 | 564 Cr | 88 Cr | 144 Cr | 123 Cr | 304 Cr | — | 421 Cr | 1,990 Cr |
Annual results
| Period | Revenue | Net Income | EBITDA | Op. Income | Gross Profit | Op. Cash Flow | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 1,819 Cr | 175 Cr | 384 Cr | 298 Cr | 985 Cr | 262 Cr | 754 Cr | 2,125 Cr |
| 2025-03-31 | 2,115 Cr | 272 Cr | 474 Cr | 377 Cr | 1,038 Cr | 330 Cr | 421 Cr | 1,990 Cr |
| 2024-03-31 | 1,816 Cr | 217 Cr | 391 Cr | 313 Cr | 702 Cr | 216 Cr | 285 Cr | 1,757 Cr |
| 2023-03-31 | 1,936 Cr | 193 Cr | 344 Cr | 280 Cr | 682 Cr | 250 Cr | 215 Cr | 1,558 Cr |
| 2022-03-31 | — | — | — | — | — | — | — | — |
Figures in ₹ crore unless stated. Ratios and margins are trailing twelve months where marked TTM.
Want charts and signals for AARTIPHARM?
Sign in for candlestick charts with Supertrend, MACD and VWAP overlays, plus watchlists and email alerts.
Sign in